NEOTIGASON 25 MG CAPSULAS DURAS
NEOTIGASON 25 MG CAPSULAS DURAS
Commercialized
Register Number
60302
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Oct 31, 1995
Dosage Form
CÁPSULA DURA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number60302
EMA Approved
No
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
ACITRETINAActive
Quantity: 25 mg
Name: ACITRETINA
ATC CLASSIFICATION (3)
D05B
D05BB
D05BB02